MK-8558
Total Payments
$1.8M
Transactions
44
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.1M | 26 | 0 |
| 2019 | $719,482 | 18 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.8M | 44 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Study of MK-8558 Drug-Drug Interaction with MK-8591 and MK-8558 Once Daily Pharmacokinetics | Merck Sharp & Dohme Corporation | $844,600 | 0 |
| An Open-Label Clinical Trial to Evaluate the Pharmacokinetics and Relative Bioavailability of Three Formulations of MK-8558 in Healthy Adult Participants | Merck Sharp & Dohme Corporation | $495,900 | 0 |
| An Open-Label Clinical Trial to Evaluate the Pharmacokinetics and RelativeBioavailability of Three Formulations of MK-8558 in Healthy Adult Participants | Merck Sharp & Dohme Corporation | $271,638 | 0 |
| A Trial to Assess the Effects of Multiple, Once Weekly Oral Doses of MK-8558 on the Single-Dose Pharmacokinetics of a Combination Oral Contraceptive Levonorgestrel and Ethinyl Estradiol in Healthy Adult Female Participants | Merck Sharp & Dohme Corporation | $134,949 | 0 |
| A Trial to Assess the Effects of Multiple, Once Weekly Oral Doses of MK-8558 on the Single-Dose Pharmacokinetics of a Combination Oral ContraceptiveLevonorgestrel and Ethinyl Estradiol in Healthy Adult Female Participants | Merck Sharp & Dohme Corporation | $90,922 | 0 |
Top Doctors Receiving Payments for MK-8558
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Lincoln, NE | $1.8M | 44 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.8M
- Total Doctors 0
- Transactions 44
About MK-8558
MK-8558 is a drug associated with $1.8M in payments to 0 healthcare providers, recorded across 44 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2019 to 2020. In 2020, $1.1M was paid across 26 transactions to 0 doctors.
The most common payment nature for MK-8558 is "Unspecified" ($1.8M, 100.0% of total).
MK-8558 is associated with 5 research studies, including "A Study of MK-8558 Drug-Drug Interaction with MK-8591 and MK-8558 Once Daily Pharmacokinetics" ($844,600).